10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
MERCK & CO., INC. | |||
Ticker: MRK Fiscal Year: 2009 | |||
Consolidated Statement of Income | |||
Period Ending Dec 31, 2009 10-K (Filed: Mar 1, 2010) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
| Sales | $ 27,428,300 | 23,850,300 | 24,197,700 |
| Costs, Expenses and Other | |||
| Materials and production | 9,018,900 | 5,582,500 | 6,140,700 |
| Marketing and administrative | 8,543,200 | 7,377,000 | 7,556,700 |
| Research and development | 5,845,000 | 4,805,300 | 4,882,800 |
| Restructuring costs | 1,633,900 | 1,032,500 | 327,100 |
| Equity income from affiliates | (2,235,000) | (2,560,600) | (2,976,500) |
| U.S. Vioxx Settlement Agreement charge | 0 | 0 | 4,850,000 |
| Other (income) expense, net | (10,669,500) | (2,318,100) | (75,200) |
| Total Costs, Expenses and Other | 12,136,500 | 13,918,600 | 20,705,600 |
| Income Before Taxes | 15,291,800 | 9,931,700 | 3,492,100 |
| Taxes on Income | 2,267,600 | 1,999,400 | 95,300 |
| Net Income | 13,024,200 | 7,932,300 | 3,396,800 |
| Less: Net Income Attributable to Noncontrolling Interests | 122,900 | 123,900 | 121,400 |
| Net Income Attributable to Merck & Co., Inc. | 12,901,300 | 7,808,400 | 3,275,400 |
| Preferred Stock Dividends | 2,100 | 0 | 0 |
| Net Income Available to Common Shareholders | 12,899,200 | 7,808,400 | 3,275,400 |
| Basic Earnings per Common Share Available to Common Shareholders | 5.67 | 3.65 | 1.51 |
| Earnings per Common Share Assuming Dilution Available to Common Shareholders | 5.65 | 3.63 | 1.49 |
| External Links | |
| MERCK & CO., INC. (MRK) Fiscal Year 2009 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |